We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+5.81%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$13B
AUM Growth
+$984M
Cap. Flow
+$180M
Cap. Flow %
1.38%
Top 10 Hldgs %
38.14%
Holding
1,449
New
52
Increased
710
Reduced
341
Closed
132

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$287M
2
DLR icon
Digital Realty Trust
DLR
+$150M
3
HR icon
Healthcare Realty
HR
+$110M
4
WELL icon
Welltower
WELL
+$106M
5
O icon
Realty Income
O
+$88.1M

Top Sells

Rank Stock Value
1
DRE
Duke Realty Corp.
DRE
+$310M
2
SPG icon
Simon Property Group
SPG
+$93.4M
3
FR icon
First Industrial Realty Trust
FR
+$90.7M
4
PSA icon
Public Storage
PSA
+$88.6M
5
DOC icon
Healthpeak Properties
DOC
+$58M

Sector Composition

Rank Sector Weight
1 Real Estate 57.53%
2 Technology 9.67%
3 Healthcare 4.73%
4 Financials 4.38%
5 Consumer Discretionary 3.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHIL
1051
DELISTED
Benson Hill, Inc.
BHIL
$24K ﹤0.01%
273
-299
-52% -$29.3K
APLS
1052
DELISTED
Apellis Pharmaceuticals
APLS
$23K ﹤0.01%
445
+48
+12% +$2.55K
BMO icon
1053
Bank of Montreal
BMO
$123B
$23K ﹤0.01%
250
-90
-26% -$8.33K
IONS icon
1054
Ionis Pharmaceuticals
IONS
$8.93B
$22K ﹤0.01%
571
+43
+8% +$1.81K
EXEL icon
1055
Exelixis
EXEL
$13.9B
$21K ﹤0.01%
1,297
+102
+9% +$1.66K
BHM icon
1056
Bluerock Homes Trust
BHM
$34.9M
$20K ﹤0.01%
+960
New +$22.4K
MDGL icon
1057
Madrigal Pharmaceuticals
MDGL
$12.6B
$20K ﹤0.01%
69
+12
+21% +$1.17K
ITCI
1058
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$20K ﹤0.01%
381
+29
+8% +$1.45K
RXDX
1059
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$19K ﹤0.01%
169
+23
+16% +$1.49K
VIEW
1060
DELISTED
View, Inc. Class A Common Stock
VIEW
$18K ﹤0.01%
+304
New +$22.2K
ALKS icon
1061
Alkermes
ALKS
$8.11B
$17K ﹤0.01%
661
+52
+9% +$1.24K
ARWR icon
1062
Arrowhead Research
ARWR
$12.1B
$17K ﹤0.01%
426
+32
+8% +$1.06K
CYTK icon
1063
Cytokinetics
CYTK
$10.6B
$17K ﹤0.01%
381
+62
+19% +$2.67K
DNLI icon
1064
Denali Therapeutics
DNLI
$3.78B
$15K ﹤0.01%
546
+88
+19% +$2.62K
EWW icon
1065
iShares MSCI Mexico ETF
EWW
$1.89B
$15K ﹤0.01%
300
– –
OUST icon
1066
Ouster
OUST
$2.11B
$15K ﹤0.01%
1,774
-2,633
-60% -$28.7K
PCVX icon
1067
Vaxcyte
PCVX
$7.65B
$15K ﹤0.01%
318
+139
+78% +$5.46K
SYNH
1068
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$15K ﹤0.01%
414
+32
+8% +$1.26K
FOLD
1069
DELISTED
Amicus Therapeutics
FOLD
$14K ﹤0.01%
1,130
+86
+8% +$968
RY icon
1070
Royal Bank of Canada
RY
$287B
$14K ﹤0.01%
150
– –
VIR icon
1071
Vir Biotechnology
VIR
$1.46B
$14K ﹤0.01%
535
+42
+9% +$1.03K
LTCH
1072
DELISTED
Latch, Inc. Common Stock
LTCH
$14K ﹤0.01%
20,395
-41,806
-67% -$38.3K
AXSM icon
1073
Axsome Therapeutics
AXSM
$11.7B
$13K ﹤0.01%
175
+46
+36% +$2.75K
CRSP icon
1074
CRISPR Therapeutics
CRSP
$4.69B
$13K ﹤0.01%
315
+26
+9% +$1.38K
HRMY icon
1075
Harmony Biosciences
HRMY
$2.08B
$13K ﹤0.01%
239
+19
+9% +$1.04K
41 42
43
44 45

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Daiwa Securities Group's Q4 2022 Portfolio in Review

As of Q4 2022, Daiwa Securities Group held 1,449 positions worth $13B, up 8.2% from $12B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Daiwa Securities Group's Q4 2022 filing shows 52 new, 710 increased, 341 reduced and 132 closed positions. Its largest new stake was Atlassian: 9,371 shares worth $1.21M. The largest sale was Duke Realty Corp., an estimated $310M.

By sector, the portfolio is most concentrated in Real Estate at 58% of assets, down from 59% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q4 2022 buy was Atlassian: 9,371 shares worth $1.21M.
  • Daiwa Securities Group added most to Prologis in Q4 2022, an estimated $287M increase.
  • Daiwa Securities Group's biggest Q4 2022 reduction was Simon Property Group, cutting an estimated $93.4M.
  • Daiwa Securities Group fully exited Duke Realty Corp. in Q4 2022, selling an estimated $310M.
  • Daiwa Securities Group's ten largest holdings make up 38% of its $13B portfolio in Q4 2022.
  • Daiwa Securities Group opened 52 new positions and closed 132 in Q4 2022.
  • Daiwa Securities Group's portfolio value rose 8.2% quarter-over-quarter to $13B.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.